Compound details
1-[3-hydroxy-4-(morpholin-4-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-(prop-2-en-1-yl)urea
| Compound ID | CDAMM00125 |
|---|---|
| Common name | 1-[3-hydroxy-4-(morpholin-4-yl)-6,8-dioxabicyclo[3.2.1]octan-2-yl]-3-(prop-2-en-1-yl)urea | IUPAC name | 1-(3-hydroxy-4-morpholin-4-yl-6,8-dioxabicyclo[3.2.1]octan-2-yl)-3-prop-2-enylurea |
| Molecular formula | C14H23N3O5 |
| Retention time | 35.07 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 314.171 | Theoretical mz | 314.171 |
| Error | 0.5 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.5383 |
| Inchi key | VDTOFIAWBIWPET-UHFFFAOYSA-N |
|---|---|
| Smiles | C=CCNC(=O)NC1C2COC(O2)C(C1O)N3CCOCC3 |
| Superclass | Organoheterocyclic compounds |
| Class | Oxepanes |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|